These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 20009297)
1. Modulation of cellular radiation responses by 2-deoxy-D-glucose and other glycolytic inhibitors: implications for cancer therapy. Kalia VK; Prabhakara S; Narayanan V J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S57-60. PubMed ID: 20009297 [TBL] [Abstract][Full Text] [Related]
2. Short-term exposure of multicellular tumor spheroids of a human glioma cell line to the glycolytic inhibitor 2-deoxy-D-glucose is more toxic than continuous exposure. Khaitan D; Chandna S; Dwarakanath SB J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S67-73. PubMed ID: 20009299 [TBL] [Abstract][Full Text] [Related]
3. Differential modification of radiation damage in 5-bromo-2-deoxy-uridine sensitized human glioma cells and PHA-stimulated peripheral leukocytes by 2-deoxy-D-glucose. Kalia VK; Devi NK Indian J Exp Biol; 1994 Sep; 32(9):637-42. PubMed ID: 7814043 [TBL] [Abstract][Full Text] [Related]
4. Potentiation of radiation effects in plateau phase human glioma cells by combination of metabolic inhibitors. Kalia VK Indian J Exp Biol; 1993 Apr; 31(4):312-5. PubMed ID: 8359829 [TBL] [Abstract][Full Text] [Related]
5. Radiosensitization by 6-aminonicotinamide and 2-deoxy-D-glucose in human cancer cells. Varshney R; Dwarakanath B; Jain V Int J Radiat Biol; 2005 May; 81(5):397-408. PubMed ID: 16076755 [TBL] [Abstract][Full Text] [Related]
6. Optimizing radiotherapy of brain tumours by a combination of temozolomide & lonidamine. Prabhakara S; Kalia VK Indian J Med Res; 2008 Aug; 128(2):140-8. PubMed ID: 19001677 [TBL] [Abstract][Full Text] [Related]
7. Optimizing radiation therapy of brain tumours by combination of 5-bromo-2-deoxy-uridine & 2-deoxy-D-glucose. Kalia VK Indian J Med Res; 1999 May; 109():182-7. PubMed ID: 10643143 [TBL] [Abstract][Full Text] [Related]
8. Heterogeneity in 2-deoxy-D-glucose-induced modifications in energetics and radiation responses of human tumor cell lines. Dwarkanath BS; Zolzer F; Chandana S; Bauch T; Adhikari JS; Muller WU; Streffer C; Jain V Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):1051-61. PubMed ID: 11429233 [TBL] [Abstract][Full Text] [Related]
9. Modification of 2-deoxy-D-glucose on radiation-and chemotherapeutic drug-induced chromosomal aberrations. Perumal V; Solomon PF; Jayanth VR J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S48-52. PubMed ID: 20009295 [TBL] [Abstract][Full Text] [Related]
10. Hematoporphyrin derivatives potentiate the radiosensitizing effects of 2-deoxy-D-glucose in cancer cells. Dwarakanath BS; Adhikari JS; Jain V Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1125-33. PubMed ID: 10192364 [TBL] [Abstract][Full Text] [Related]
11. Effects of gamma-rays and glucose analogs on the energy metabolism of a cell line derived from human cerebral glioma. Dwarakanath BS; Jain V Indian J Biochem Biophys; 1991 Jun; 28(3):203-9. PubMed ID: 1786971 [TBL] [Abstract][Full Text] [Related]
12. Glycolytic inhibitor, 2-deoxy-D-glucose, does not enhance radiation-induced apoptosis in mouse thymocytes and splenocytes in vitro. Swamy RK; Manickam J; Adhikari JS; Dwarakanath BS Indian J Exp Biol; 2005 Aug; 43(8):686-92. PubMed ID: 16121709 [TBL] [Abstract][Full Text] [Related]
13. Modification of radiation damage in transformed mammalian cells by 5-bromo-2-deoxy-uridine and 2-deoxy-D-glucose. Kalia VK; Jain V Indian J Exp Biol; 1993 Mar; 31(3):224-30. PubMed ID: 8500838 [TBL] [Abstract][Full Text] [Related]
14. Effects of 5-bromo-2-deoxy-uridine and 2-deoxy-D-glucose on the radiosensitivity of proliferating transformed mammalian cells. Kalia VK; Jain V Indian J Exp Biol; 1991 Sep; 29(9):826-30. PubMed ID: 1794865 [TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity, radiosensitization, and chemosensitization of tumor cells by 2-deoxy-D-glucose in vitro. Dwarakanath BS J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S27-31. PubMed ID: 20009290 [TBL] [Abstract][Full Text] [Related]
16. The proliferative response of hela cells to 2-deoxy-D-glucose under hypoxic or anoxic conditions: an analogue for studying some properties of in vivo solid cancers. Anderson KM; Tsui P; Guinan P; Rubenstein M Anticancer Res; 2006; 26(6B):4155-62. PubMed ID: 17201127 [TBL] [Abstract][Full Text] [Related]
17. Light-induced photoactivation of hypericin affects the energy metabolism of human glioma cells by inhibiting hexokinase bound to mitochondria. Miccoli L; Beurdeley-Thomas A; De Pinieux G; Sureau F; Oudard S; Dutrillaux B; Poupon MF Cancer Res; 1998 Dec; 58(24):5777-86. PubMed ID: 9865736 [TBL] [Abstract][Full Text] [Related]
18. Differential mechanisms of radiosensitization by 2-deoxy-D-glucose in the monolayers and multicellular spheroids of a human glioma cell line. Khaitan D; Chandna S; Arya MB; Dwarakanath BS Cancer Biol Ther; 2006 Sep; 5(9):1142-51. PubMed ID: 16855378 [TBL] [Abstract][Full Text] [Related]
19. Clinical studies for improving radiotherapy with 2-deoxy-D-glucose: present status and future prospects. Dwarakanath BS; Singh D; Banerji AK; Sarin R; Venkataramana NK; Jalali R; Vishwanath PN; Mohanti BK; Tripathi RP; Kalia VK; Jain V J Cancer Res Ther; 2009 Sep; 5 Suppl 1():S21-6. PubMed ID: 20009289 [TBL] [Abstract][Full Text] [Related]
20. Contribution of oxidative stress to radiosensitization by a combination of 2-DG and 6-AN in human cancer cell line. Varshney R; Adhikari JS; Dwarakanath BS Indian J Exp Biol; 2003 Dec; 41(12):1384-91. PubMed ID: 15320490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]